52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol ANPCY
CUSIP 03476V100
DR Venue OTC
DR ISIN US03476V1008
Ratio DR:ORD 1:10
Underlying ISIN GB0034330679
Country United Kingdom
Effective Date Apr 30, 2020
Depositary CIT (Sponsored)
Industry Pharma. & Biotech.
ANGLE is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. ANGLE's lead product is the Parsortix cell separation system, which can capture very rare cells from blood. This includes circulating tumour cells (CTCs) in cancer patient blood â?? even when there is less than one CTC in one billion healthy cells. The resulting liquid biopsy (simple blood test) enables the investigation of mutations in the patient's cancer for personalised cancer care.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jul.25 0.79 2,615 187
Jun.25 1.03 15,385 1,099
May.25 1.08 5,121 301

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE